newdrugapprovals.org
PNQ 370 useful in treating Parkinson’s disease from ADVINUS
2016 PNQ 370 Advinus Therapeutics Ltd Adenosine A2a receptor antagonist for treating disease or disorder susceptible to improvement by antagonism of A2A receptor. Advinus Therapeutics is i…